Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
Completed · Phase 1 · Has a placebo group
Conditions studied: Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer
In brief
Green tea extract contains ingredients that may prevent or slow the growth of prostate cancer. This phase I trial is studying how well green tea extract works in treating patients with prostate cancer undergoing surgery to remove the prostate
Key facts
- Study ID
- NCT00459407
- Run by
- National Cancer Institute (NCI)
- People needed
- 50
- Starts
- 2007-03-01
- Expected to finish
- 2010-08-01
- Last updated by the study team
- 2014-10-08
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Arizona Cancer Center - Tucson — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.